76 related articles for article (PubMed ID: 18044789)
1. Long term safety: not only a drug eluting stents issue.
Fineschi M; Zacà V; Gori T
Catheter Cardiovasc Interv; 2007 Dec; 70(7):1051; author reply 1052. PubMed ID: 18044789
[No Abstract] [Full Text] [Related]
2. Treatment of drug-eluting stent restenosis: a sandwich may not be the best combo.
Belardi J
Catheter Cardiovasc Interv; 2008 Apr; 71(5):599. PubMed ID: 18360848
[No Abstract] [Full Text] [Related]
3. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
4. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
5. "Anti-healing" versus "pro-healing".
Seth DA
Catheter Cardiovasc Interv; 2008 Apr; 71(5):605-6. PubMed ID: 18360850
[No Abstract] [Full Text] [Related]
6. Drug-eluting stent in saphenous vein graft lesions.
Kornowski R
Catheter Cardiovasc Interv; 2008 Jun; 71(7):894-5. PubMed ID: 18498140
[No Abstract] [Full Text] [Related]
7. Cost-effectiveness of the real-world use of drug-eluting stents at 9-month follow-up: results from the Sicilian DES Registry.
Tamburino C; Barbagallo R; Capodanno D; di Matteo S; Colombo GL; Recchia M; Ciriminna S;
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):322-9. PubMed ID: 19430343
[TBL] [Abstract][Full Text] [Related]
8. Treatment of patients with in-stent restenosis.
Alfonso F; Pérez-Vizcayno MJ; Cruz A; García J; Jimenez-Quevedo P; Escaned J; Hernandez R
EuroIntervention; 2009 May; 5 Suppl D():D70-8. PubMed ID: 19736076
[TBL] [Abstract][Full Text] [Related]
9. Drug-eluting stent thrombosis.
Stähli BE; Camici GG; Tanner FC
Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):45-52. PubMed ID: 19124388
[TBL] [Abstract][Full Text] [Related]
10. Paclitaxel-eluting balloon: from bench to bed.
De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
[TBL] [Abstract][Full Text] [Related]
11. Mounting evidence for safety and improved outcomes of drug-eluting stenting: but is it the stent?
King SB; Hannan EL
Circulation; 2008 Oct; 118(18):1783-4. PubMed ID: 18852362
[No Abstract] [Full Text] [Related]
12. A sweet summer for drug-eluting stents in patients with diabetes mellitus.
Costa MA
Catheter Cardiovasc Interv; 2008 Nov; 72(5):610-1. PubMed ID: 18949774
[No Abstract] [Full Text] [Related]
13. Secondary revascularisation following intracoronary brachytherapy.
Sabaté M
EuroIntervention; 2009 May; 5 Suppl D():D121-6. PubMed ID: 19736060
[TBL] [Abstract][Full Text] [Related]
14. Accelerated in-stent restenosis after bare-metal stenting of a myocardial bridge and successful treatment with drug-eluting stenting.
Ziakas A; Gavrilidis S; Parisiadou A; Parxaridis G
Minerva Cardioangiol; 2007 Dec; 55(6):839-43. PubMed ID: 18091650
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical outcomes of real-world experience using sirolimus-eluting stents in saphenous vein graft disease.
Ramana RK; Ronan A; Cohoon K; Homan D; Sutherland J; Steen L; Liu J; Loeb H; Lewis BE
Catheter Cardiovasc Interv; 2008 Jun; 71(7):886-93. PubMed ID: 18412238
[TBL] [Abstract][Full Text] [Related]
16. Trifurcation left main coronary artery percutaneous revascularization--pushing catheters and envelopes.
Moliterno DJ
Catheter Cardiovasc Interv; 2009 Jan; 73(1):32-3. PubMed ID: 19089933
[No Abstract] [Full Text] [Related]
17. Drug eluting stents in AMI: keep the data coming.
Vetrovec GW
Catheter Cardiovasc Interv; 2008 May; 71(6):770-1. PubMed ID: 18412075
[No Abstract] [Full Text] [Related]
18. Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
Byrne RA; Kastrati A
Catheter Cardiovasc Interv; 2008 Dec; 72(7):944-9. PubMed ID: 19021280
[TBL] [Abstract][Full Text] [Related]
19. Clinical presentation of patients with late target lesion revascularization.
Kaneda H
Catheter Cardiovasc Interv; 2008 Nov; 72(5):749. PubMed ID: 18942148
[No Abstract] [Full Text] [Related]
20. [Efficacy and safety of implantation of multiple drug-eluting stents].
Fu Q; Li ZL; Wu HC
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jan; 28(1):110-2. PubMed ID: 18227039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
